Evidence map›Paper›PMID 23415952›Full record

ReviewAdvanced drug delivery reviews2013

In vitro and in vivo models for the study of oral delivery of nanoparticles.

Jennifer M Gamboa, Kam W Leong

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Emerging advances in intestinal models for in vitro preclinical research.American journal of physiology. Gastrointestinal and liver physiology · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Chitosan Nanoparticle-EncapsulatedInternational journal of molecular sciences · 2025
    Article
  11. Article
  12. Review
  13. Current State of Scientific Knowledge on Curcumin Encapsulation and Applications.Recent advances in food, nutrition & agriculture · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jennifer M GamboaDepartment of Biomedical Engineering, Duke University, 101 Science Drive, Durham, NC 27708, USA.
Kam W Leong

Funding

Oral Therapy for Hemophilia AR01HL109442 · NHLBI · UNIVERSITY OF FLORIDA · PI DANIELL, HENRY, HERZOG, ROLAND W. · 2011 to 2015
$3.5M
Overcoming Immunosenescence by Nanoparticle-Mediated ActivationR01AI096305 · NIAID · DUKE UNIVERSITY · PI ABRAHAM, SOMAN N, LEONG, KAM W · 2012 to 2016
$1.8M
Oral Nonviral Gene Delivery for Hemophilla AR01HL089764 · NHLBI · DUKE UNIVERSITY · PI LEONG, KAM W · 2008 to 2011
$1.7M
Derivation of Functional Neurons from Human Adult Cells by Nonviral Gene DeliveryR21EB015300 · NIBIB · DUKE UNIVERSITY · PI LEONG, KAM W · 2012 to 2013
$421k
NHLBI NIH HHS R01 HL089764NHLBI NIH HHS R01 HL109442NIAID NIH HHS R01 AI096305NIBIB NIH HHS R21 EB015300
6 · The paper itself

Abstract

Oral delivery is an attractive route to deliver therapeutics via nanoparticles due to its ease of administration and patient compliance. This review discusses laboratory techniques for studying oral delivery of nanoparticles, which offer protection of cargo through the gastrointestinal tract. Some of the difficulties in modeling oral delivery include the harsh acidic environment, variable pH, and the tight monolayer of endothelial cells present throughout the gastrointestinal tract. The use of in vitro techniques including the Transwell ® system, simulated gastric/intestinal fluid, and diffusion chambers addresses these challenges. When studying effects after oral delivery in vivo, bioimaging of nanoparticle biodistribution using radioactive markers has been popular. Functional assays such as immune response and systemic protein concentration analysis can further define the merits of the oral delivery systems. As biologics become increasingly more important in chronic therapies, nanoparticle-mediated oral delivery will assume greater prominence, and more sophisticated in vitro and in vivo models will be required.

Indexed as

Models, BiologicalAdministration, OralAnimalsBiological AvailabilityCell LineDisease Models, AnimalDrug CarriersDrug Evaluation, PreclinicalGastrointestinal TractHematologic TestsHumansImmunoassayNanoparticlesPolymerase Chain ReactionRadionuclide ImagingDrug Carriers

Identifiers

PMID23415952
PMCPMC3773489

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.